Chongwen Xu

Dr. Chongwen Xu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2023 in Molecules and Cells
Verified
Journal Article
Open access
PDF file
YSYuan Shao
Yuan Shao
WRWanli Ren
Wanli Ren
HDHao Dai
Hao Dai
FYFangli Yang
Fangli Yang
XLXiang Li
Xiang Li
CXChongwen Xu
Chongwen Xu
Yuan Shao, Wanli Ren, Hao Dai, Fangli Yang, Xiang Li, Shaoqiang Zhang, Junsong Liu, Xiaobao Yao, Qian Zhao, Xin Sun, Zhiwei Zheng, and Chongwen Xu. Mol. Cells -0001;0:. https://doi.org/10.14348/molcells.2022.2242

20 February 2024 in Cell Biology and Toxicology
Verified
Journal Article
Open access
PDF file
JZJinxiang Zhu
Jinxiang Zhu
LGLongwei Guo
Longwei Guo
HDHao Dai
Hao Dai
ZZZhiwei Zheng
Zhiwei Zheng
JYJinfeng Yan
Jinfeng Yan
CXChongwen Xu
Chongwen Xu
: Background: RING Finger Protein 115 (RNF115), a notable E3 ligase, is known to modulate tumorigenesis and metastasis. In our investigation, we endeavor to unravel the putative function and inherent mechanism through which RNF115 influences the evolution of thyroid carcinoma (THCA). Methods: We analyzed RNF115 expression in THCA using the Cancer Genome Atlas (TCGA) database. The influence of RNF115 on the progression of THCA was evaluated using both in vitro and in vivo experimental approaches. The protein regulated by RNF115 was identified through bioinformatics analysis, and its biological significance was further explored. Results: In both THCA tissues and cells, RNF115 showed elevated expression levels. Enhanced expression of RNF115 fostered cell proliferation, tumor growth, and the exacerbation of epithelial-mesenchymal transition (EMT) in THCA, while also promoting tumor lung metastasis. Bioinformatics analysis identified cyclin-dependent kinase 10 (CDK10) as a downstream target of RNF115, which was found to be ubiquitinated and degraded by RNF115 in THCA cells. Functionally, overexpression of CDK10 was found to counteract the promotion of malignant phenotype in THCA induced by RNF115. From a mechanistic perspective, RNF115 activated the Raf-1 pathway and enhanced cancer cell cycle progression by degrading CDK10 in THCA cells. Conclusion: RNF115 triggers cell proliferation, EMT, and tumor metastasis by ubiquitinating and degrading CDK10. The regulation of the Raf-1 pathway and cell cycle progression in THCA may be profoundly influenced by this process.

31 January 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
LFLei Feng
Lei Feng
RWRui Wang
Rui Wang
QZQian Zhao
Qian Zhao
JWJun Wang
Jun Wang
GLGang Luo
Gang Luo
CXChongwen Xu
Chongwen Xu
Background: Metastatic colorectal cancer (mCRC) is a heterogeneous disease, often associated with poor outcomes and resistance to therapies. The racial variations in the molecular and microbiological profiles of mCRC patients, however, remain under-explored.Methods: Using RNA-SEQ data, we extracted and analyzed actively transcribing microbiota within the tumor milieu, ensuring that the identified bacteria were not merely transient inhabitants but engaged in the tumor ecosystem. Also, we independently acquired samples from 12 mCRC patients, specifically, 6 White individuals and 6 of Black or African American descent. These samples underwent 16S rRNA sequencing.Results: Our study revealed notable racial disparities in the molecular signatures and microbiota profiles of mCRC patients. The intersection of these data showcased the potential modulating effects of specific bacteria on gene expression. Particularly, the bacteria Helicobacter cinaedi and Sphingobium herbicidovorans emerged as significant influencers, with strong correlations to the genes SELENBP1 and SNORA38, respectively.Discussion: These findings underscore the intricate interplay between host genomics and actively transcribing tumor microbiota in mCRC’s pathogenesis. The identified correlations between specific bacteria and genes highlight potential avenues for targeted therapies and a more personalized therapeutic approach.

7 September 2026 in Cell Biology and Toxicology
Verified
Journal Article
Open access
PDF file
JZJinxiang Zhu
Jinxiang Zhu
LGLongwei Guo
Longwei Guo
HDHao Dai
Hao Dai
ZZZhiwei Zheng
Zhiwei Zheng
JYJinfeng Yan
Jinfeng Yan
CXChongwen Xu
Chongwen Xu